Literature DB >> 19436813

Late stent thrombosis associated with heavy exercise.

Ziya Simsek1, Sakir Arslan, Fuat Gundogdu.   

Abstract

Bare-metal stents are commonly used in the treatment of coronary artery disease. Stent thrombosis usually occurs within the first 48 hours after stent deployment. After a week, the incidence of thrombosis is low. Late stent thrombosis (after 30 days) is rarely seen; however, its clinical outcomes are severe 30-day mortality rates of 20% to 48% and myocardial infarction rates of 60% to 70%. Herein, we present the case and discuss the treatment of a patient who, after heavy exercise, experienced acute myocardial infarction due to late thrombosis in a bare-metal stent.A 54-year-old man presented with unstable angina pectoris. Coronary angiography revealed critical occlusion of the middle right coronary artery. A bare-metal stent was implanted, and he was discharged from the hospital on a medical regimen. Eleven months later, he presented with acute myocardial infarction, which had developed after heavy exercise. Coronary angiography revealed occlusion of the stent in the right coronary artery. After the occlusion was crossed with a guidewire, balloon angioplasty was applied, and Thrombosis-in-Myocardial-Infarction (TIMI)-3 flow was restored. The patient was asymptomatic during his 5-day hospitalization and was discharged on dual antiplatelet therapy.In addition to presenting this patient's case, we discuss mechanisms that may contribute to late stent thrombosis, implications of the condition, and preventive therapy.

Entities:  

Keywords:  Aspirin/administration & dosage/therapeutic use; blood vessel prosthesis implantation/adverse effects; coronary disease/therapy; coronary restenosis/etiology/pathology/prevention & control/therapy; coronary thrombosis/etiology/therapy; exercise/physiology; myocardial revascularization; platelet aggregation inhibitors/administration & dosage; postoperative complications/etiology; stents/adverse effects; treatment outcome

Mesh:

Substances:

Year:  2009        PMID: 19436813      PMCID: PMC2676600     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  16 in total

1.  Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials.

Authors:  D E Cutlip; D S Baim; K K Ho; J J Popma; A J Lansky; D J Cohen; J P Carrozza; M S Chauhan; O Rodriguez; R E Kuntz
Journal:  Circulation       Date:  2001-04-17       Impact factor: 29.690

2.  Stent thrombosis: it's never too late!

Authors:  John M Lasala
Journal:  Catheter Cardiovasc Interv       Date:  2002-02       Impact factor: 2.692

3.  Cause of in-hospital death in 12,232 consecutive patients undergoing percutaneous transluminal coronary angioplasty. The Northern New England Cardiovascular Disease Study Group.

Authors:  D J Malenka; D O'Rourke; M A Miller; M J Hearne; S Shubrooks; M A Kellett; J F Robb; J R O'Meara; P VerLee; W A Bradley; D Wennberg; T Ryan; P T Vaitkus; B Hettleman; M W Watkins; P D McGrath; G T O'Connor
Journal:  Am Heart J       Date:  1999-04       Impact factor: 4.749

4.  ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine.

Authors:  Jeffrey L Anderson; Cynthia D Adams; Elliott M Antman; Charles R Bridges; Robert M Califf; Donald E Casey; William E Chavey; Francis M Fesmire; Judith S Hochman; Thomas N Levin; A Michael Lincoff; Eric D Peterson; Pierre Theroux; Nanette Kass Wenger; R Scott Wright; Sidney C Smith; Alice K Jacobs; Jonathan L Halperin; Sharon A Hunt; Harlan M Krumholz; Frederick G Kushner; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2007-08-06       Impact factor: 29.690

5.  Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome.

Authors:  Peter Wenaweser; Christoph Rey; Franz R Eberli; Mario Togni; David Tüller; Stefan Locher; Andrea Remondino; Christian Seiler; Otto M Hess; Bernhard Meier; Stephan Windecker
Journal:  Eur Heart J       Date:  2005-02-23       Impact factor: 29.983

6.  Delayed coronary occlusion after successful percutaneous transluminal coronary angioplasty: association with exercise testing.

Authors:  H Dash
Journal:  Am J Cardiol       Date:  1983-11-01       Impact factor: 2.778

7.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.

Authors:  Steven R Steinhubl; Peter B Berger; J Tift Mann; Edward T A Fry; Augustin DeLago; Charles Wilmer; Eric J Topol
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

8.  Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.

Authors:  S R Mehta; S Yusuf; R J Peters; M E Bertrand; B S Lewis; M K Natarajan; K Malmberg; H Rupprecht; F Zhao; S Chrolavicius; I Copland; K A Fox
Journal:  Lancet       Date:  2001-08-18       Impact factor: 79.321

9.  Pathological mechanisms of fatal late coronary stent thrombosis in humans.

Authors:  Andrew Farb; Allen P Burke; Frank D Kolodgie; Renu Virmani
Journal:  Circulation       Date:  2003-09-22       Impact factor: 29.690

10.  Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury.

Authors:  J F Eidt; J Ashton; P Golino; J McNatt; L M Buja; J T Willerson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.